Fingerprint
Dive into the research topics of 'FDA approval: Palbociclib for the treatment of postmenopausal patients with estrogen receptor-positive, HER2-negative metastatic breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically